11 research outputs found
Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry
No full textEverolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure
No full textOptimal treatment of recurrent restenosis lesions after drug-eluting stent implantation for in-stent restenosis lesions
No full textComparison of Long-Term Clinical Outcome After Sirolimus-Eluting Stent Implantation in Patients With and Without Hemodialysis
No full textAngiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions
No full text
In-Stent Restenosis: Definition, Entity of the Problem, Etiopathogenesis and Treatment Options
No full textIn-stent restenosis (ISR) still represents a frequent limitation of percutaneous coronary intervention despite the introduction of latest-generation drug-eluting stents (DES), drastically lowering the overall incidence of ISR. Thus, the treatment of DES ISR remains a real brainteaser for interventional cardiologists
